Viewing Study NCT00275132


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2025-12-31 @ 10:24 PM
Study NCT ID: NCT00275132
Status: COMPLETED
Last Update Posted: 2014-12-03
First Post: 2006-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Organization: